Focusing the optimization of immunological response and tissue integration with implant surfaces LONGMONT, Colo., Oct. 13, 2022 /PRNewswire/ — Implant Surfaces LLC and CMDC Labs have agreed to expand a joint development effort to pursue immunological and tissue integration research…
News
Collaborative Partnership Issues $6 Million to 16 Community-based Organizations
Colorado continues commitment to newcomer wellbeing through crucial program expansion DENVER, June 1, 2023 /PRNewswire/ — The Refugee Integration Fund recently awarded $6 million in grants in support of 16 organizations providing programs that address […]
News
Manufacturing roundup: AGC Biologics to manufacture diabetes therapy; Cambrex caps acquisition of Snapdragon Chemistry
The Washington-based CDMO AGC Biologics has been tapped to manufacture the type 1 diabetes treatment Tzield from Provention Bio. AGC Biologics will produce Tzield at its Seattle protein biologics site. It was chosen after AGC […]
News
New Study Uncovers Key Insights Into Protein Interactions in Duchenne Muscular Dystrophy, Paving Way for More Targeted Therapies
A groundbreaking study has shed light on the complex interactions between dystrophin, a protein critical to muscle stability, and its partner protein, dystrobrevin, offering new pathways for understanding and treating Duchenne Muscular Dystrophy (DMD). Click […]
